Ido Sloma

1.1k total citations
12 papers, 382 citations indexed

About

Ido Sloma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ido Sloma has authored 12 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ido Sloma's work include Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Ido Sloma is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Ido Sloma collaborates with scholars based in United States, Israel and India. Ido Sloma's co-authors include Sol Efroni, Evan Burns, Iván Mascanfroni, Sílvio M. Vieira, Simon C. Robson, Vijay K. Kuchroo, Lior Mayo, Bonny Patel, Rotem Ben‐Hamo and Francisco J. Quintana and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Nature Immunology.

In The Last Decade

Ido Sloma

11 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ido Sloma United States 7 241 94 91 43 34 12 382
Olga Klimenkova Germany 7 150 0.6× 92 1.0× 153 1.7× 25 0.6× 16 0.5× 14 388
Yong‐Min Lin China 13 167 0.7× 77 0.8× 155 1.7× 99 2.3× 13 0.4× 24 389
Andrea Gorzanelli Italy 7 332 1.4× 57 0.6× 86 0.9× 12 0.3× 23 0.7× 7 429
Esther Zumaquero United States 8 165 0.7× 72 0.8× 152 1.7× 44 1.0× 10 0.3× 12 367
Giuseppina Conteduca Italy 10 177 0.7× 73 0.8× 85 0.9× 21 0.5× 97 2.9× 24 385
Yoshitomo Hayama Japan 7 321 1.3× 58 0.6× 246 2.7× 11 0.3× 17 0.5× 12 551
Laurent Catala France 6 496 2.1× 238 2.5× 162 1.8× 11 0.3× 18 0.5× 8 711
Daniela DiFranco Italy 8 285 1.2× 88 0.9× 173 1.9× 86 2.0× 41 1.2× 10 497
Elizabeth A. Zambricki United States 8 361 1.5× 89 0.9× 93 1.0× 9 0.2× 16 0.5× 11 522
Dingxin Pan United Kingdom 10 140 0.6× 31 0.3× 136 1.5× 21 0.5× 6 0.2× 14 356

Countries citing papers authored by Ido Sloma

Since Specialization
Citations

This map shows the geographic impact of Ido Sloma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ido Sloma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ido Sloma more than expected).

Fields of papers citing papers by Ido Sloma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ido Sloma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ido Sloma. The network helps show where Ido Sloma may publish in the future.

Co-authorship network of co-authors of Ido Sloma

This figure shows the co-authorship network connecting the top 25 collaborators of Ido Sloma. A scholar is included among the top collaborators of Ido Sloma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ido Sloma. Ido Sloma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sadhukhan, Pritam, Mingxiao Feng, Ido Sloma, et al.. (2024). YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation. Journal of Clinical Investigation. 135(2). 8 indexed citations
2.
Silberberg, Gilad, Brandon L. Walling, Amy Wesa, et al.. (2023). Pharmaco-Pheno-Multiomic Integration Reveals Biomarker Profiles and Therapeutic Response Prediction Models in Leukemia and Ovarian Cancer. Archives of Clinical and Biomedical Research. 7(1).
3.
Sadhukhan, Pritam, Mingxiao Feng, Ido Sloma, et al.. (2021). Abstract P174: YAP1 drives immune suppression in urothelial carcinoma of bladder. Molecular Cancer Therapeutics. 20(12_Supplement). P174–P174. 1 indexed citations
4.
Gajan, Ambikai, Sharon K. Michelhaugh, Ido Sloma, et al.. (2019). Alternative Splicing of RAD6B and Not RAD6A Is Selectively Increased in Melanoma: Identification and Functional Characterization. Cells. 8(11). 1375–1375. 6 indexed citations
5.
Subbannayya, Tejaswini, Alex Zhavoronkov, Ivan V. Ozerov, et al.. (2019). Abstract 3443: Doublecortin-like kinase 1 (DCLK1) is novel Notch pathway signaling regulator in HNSCC. Cancer Research. 79(13_Supplement). 3443–3443. 1 indexed citations
6.
Solomon, Oz, Ido Sloma, Rami Rauch, et al.. (2019). AL101 mediated tumor inhibition in notch-altered TNBC PDX models.. Journal of Clinical Oncology. 37(15_suppl). 1064–1064. 16 indexed citations
7.
Erhart, Friedrich, Johanna Buchroithner, Katrin Fischhuber, et al.. (2018). Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. Acta Neuropathologica Communications. 6(1). 135–135. 43 indexed citations
8.
Subbannayya, Tejaswini, Jayshree Advani, Alex Zhavoronkov, et al.. (2018). Abstract 4512: Doublecortin-like kinase 1 (DCLK1) correlates with Notch pathway signaling, controls metastatic characteristics in head and neck cancer. Cancer Research. 78(13_Supplement). 4512–4512. 1 indexed citations
9.
Brait, Mariana, Evgeny Izumchenko, Luciane T. Kagohara, et al.. (2017). Comparative mutational landscape analysis of patient-derived tumour xenografts. British Journal of Cancer. 116(4). 515–523. 10 indexed citations
10.
Makarev, Eugene, Adrian D. Schubert, Riya R. Kanherkar, et al.. (2017). In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia. Cell Death Discovery. 3(1). 17022–17022. 26 indexed citations
11.
Brait, Mariana, Evgeny Izumchenko, Luciane T. Kagohara, et al.. (2016). Abstract 3640: Validation of qBiomarker as an accurate and efficient mutation detection method in a comprehensive analysis of patient-derived tumor xenografts. Cancer Research. 76(14_Supplement). 3640–3640. 1 indexed citations
12.
Mascanfroni, Iván, Ada Yeste, Sílvio M. Vieira, et al.. (2013). IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nature Immunology. 14(10). 1054–1063. 269 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Klimenkova Breakdown of academic impact, for papers by Yong‐Min Lin Breakdown of academic impact, for papers by Andrea Gorzanelli Breakdown of academic impact, for papers by Esther Zumaquero Breakdown of academic impact, for papers by Giuseppina Conteduca Breakdown of academic impact, for papers by Yoshitomo Hayama Breakdown of academic impact, for papers by Laurent Catala Breakdown of academic impact, for papers by Daniela DiFranco Breakdown of academic impact, for papers by Elizabeth A. Zambricki Breakdown of academic impact, for papers by Dingxin Pan
Rankless by CCL
2026